Production (Stage)
Theratechnologies Inc.
TH.TO
TSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.73M | 19.05M | 25.00M | 22.60M | 22.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.73M | 19.05M | 25.00M | 22.60M | 22.02M |
| Cost of Revenue | 4.70M | 3.48M | 6.10M | 4.52M | 4.55M |
| Gross Profit | 13.03M | 15.56M | 18.91M | 18.08M | 17.47M |
| SG&A Expenses | 12.32M | 10.70M | 10.66M | 9.25M | 9.46M |
| Depreciation & Amortization | -- | -- | 1.44M | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.63M | 17.15M | 24.08M | 16.39M | 18.73M |
| Operating Income | -1.90M | 1.90M | 919.00K | 6.21M | 3.29M |
| Income Before Tax | -4.22M | 424.00K | -6.88M | 3.85M | 1.11M |
| Income Tax Expenses | 246.00K | 307.00K | 1.02M | 756.00K | 118.00K |
| Earnings from Continuing Operations | -4.46M | 117.00K | -7.90M | 3.09M | 987.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.46M | 117.00K | -7.90M | 3.09M | 987.00K |
| EBIT | -1.90M | 1.90M | 919.00K | 6.21M | 3.29M |
| EBITDA | -1.51M | 2.31M | 1.33M | 6.62M | 4.47M |
| EPS Basic | -0.09 | 0.00 | -0.16 | 0.06 | 0.02 |
| Normalized Basic EPS | -0.04 | 0.01 | -0.01 | 0.05 | 0.01 |
| EPS Diluted | -0.09 | 0.00 | -0.16 | 0.06 | 0.02 |
| Normalized Diluted EPS | -0.04 | 0.01 | -0.01 | 0.05 | 0.01 |
| Average Basic Shares Outstanding | 49.36M | 49.36M | 49.36M | 49.36M | 49.36M |
| Average Diluted Shares Outstanding | 49.36M | 50.40M | 49.36M | 49.37M | 49.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |